Factors affecting survival in juvenile systemic sclerosis

G. Martini, F. Vittadello, Ö Kasapçopur, S. Magni Manzoni, F. Corona, C. Duarte-Salazar, D. Nemcova, C. A. Len, S. M. Garay, S. Ullman, F. Zulian, Ruben Cuttica, Ricardo Russo, Graciela Espada, María Teresa Apaz, Maria Odete Hilario, Ana Paola Lotito, Claudia Machado, Flavio Sztajnbok, Sheila Knupp F De OliveiraBernadete de I Liphaus, Clovis A. Almeida da Silva, Traudel Saurenmann, Susan Nielsen, Rebecca Ten Cate, Lisette Van Suijlekom-Smit, Hermann Girschick, Ivan Foeldvari, Gerd Horneff, Carine Wouters, Paul Galea, Patricia Woo, Rosa Merino, Rosa Roldan Molina, Maria Luz Gàmir, Joan Ros, Michel Fischbach, Angelo Ravelli, Antonella Buoncompagni, Elisabetta Cortis, Fernanda Falcini, Maria Giannina Alpigiani, Clodoveo Ferri, Andrey Scegolev, Dana Němcová, Ilonka Orbàn, Henryka Mazur Zielińska, Elzbieta Musiej-Nowakowska, Tadej Avcin, Pasic Srdjan, Roksanda Stojanovic, Gordana Susic, Mukamel Masha, Yoseph Uziel, Galina A. Lyskina, Sulaiman Al-Mayouf, Anne Eberhard, Gloria Higgins, Lynn Punaro, Audrey Nelson, Robert Sundel, Terry L. Moore, Balu H. Athreya, Thomas Lehman

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Objectives. To determine whether demographic, clinical and immunological features may predict the outcome in juvenile SSc (JSSc). Methods. Clinical and laboratory characteristics of patients with JSSc collected from paediatric rheumatology centres worldwide were analysed. First, univariate tests identified those features significantly related with fatal outcome, and then multivariate logistic regression analysis was applied to determine the predictors of mortality. Results. One hundred and thirty-four patients from 40 centres were eligible for the analysis. Sixteen patients died and a rapidly fatal course was observed in most of them: 4/16 died within 1 yr after diagnosis and 10/16 within 5 yrs. At the moment of diagnosis, patients with poor outcome showed a significantly higher frequency of internal organ involvement, particularly cardiac, respiratory and gastrointestinal systems. No significant difference emerged for entity of skin, vascular and musculo-skeletal involvement, nor for auto-antibodies profile and laboratory tests. Multivariate analysis showed the following factors to be significant predictors of mortality: fibrosis on chest X-rays [odds ratio (OR) 11.2], raised creatinine levels (OR 22.7) and pericarditis (OR 41.3), while a short disease duration at diagnosis conferred protection (OR 0.3). Conclusions. All patients with JSSc and fatal outcome were affected by the diffuse form of the disease, and most of them showed a very rapid progression and early signs of internal organ involvement. This suggests that, in children, SSc may have two possible courses: a rapid development of internal organ failure leading to severe disability and eventually to death, or a slow course of the disease with lower mortality.

Original languageEnglish (US)
Pages (from-to)119-122
Number of pages4
JournalRheumatology
Volume48
Issue number2
DOIs
StatePublished - 2009

Fingerprint

Systemic Scleroderma
Odds Ratio
Survival
Fatal Outcome
Mortality
Pericarditis
Rheumatology
Respiratory System
Blood Vessels
Creatinine
Fibrosis
Thorax
Multivariate Analysis
Logistic Models
Regression Analysis
X-Rays
Demography
Pediatrics
Skin
Antibodies

Keywords

  • Child
  • Mortality
  • Outcome
  • Scleroderma
  • Systemic sclerosis

ASJC Scopus subject areas

  • Rheumatology
  • Pharmacology (medical)

Cite this

Martini, G., Vittadello, F., Kasapçopur, Ö., Magni Manzoni, S., Corona, F., Duarte-Salazar, C., ... Lehman, T. (2009). Factors affecting survival in juvenile systemic sclerosis. Rheumatology, 48(2), 119-122. https://doi.org/10.1093/rheumatology/ken388

Factors affecting survival in juvenile systemic sclerosis. / Martini, G.; Vittadello, F.; Kasapçopur, Ö; Magni Manzoni, S.; Corona, F.; Duarte-Salazar, C.; Nemcova, D.; Len, C. A.; Garay, S. M.; Ullman, S.; Zulian, F.; Cuttica, Ruben; Russo, Ricardo; Espada, Graciela; Apaz, María Teresa; Hilario, Maria Odete; Lotito, Ana Paola; Machado, Claudia; Sztajnbok, Flavio; De Oliveira, Sheila Knupp F; Liphaus, Bernadete de I; Almeida da Silva, Clovis A.; Saurenmann, Traudel; Nielsen, Susan; Cate, Rebecca Ten; Van Suijlekom-Smit, Lisette; Girschick, Hermann; Foeldvari, Ivan; Horneff, Gerd; Wouters, Carine; Galea, Paul; Woo, Patricia; Merino, Rosa; Roldan Molina, Rosa; Gàmir, Maria Luz; Ros, Joan; Fischbach, Michel; Ravelli, Angelo; Buoncompagni, Antonella; Cortis, Elisabetta; Falcini, Fernanda; Alpigiani, Maria Giannina; Ferri, Clodoveo; Scegolev, Andrey; Němcová, Dana; Orbàn, Ilonka; Zielińska, Henryka Mazur; Musiej-Nowakowska, Elzbieta; Avcin, Tadej; Srdjan, Pasic; Stojanovic, Roksanda; Susic, Gordana; Masha, Mukamel; Uziel, Yoseph; Lyskina, Galina A.; Al-Mayouf, Sulaiman; Eberhard, Anne; Higgins, Gloria; Punaro, Lynn; Nelson, Audrey; Sundel, Robert; Moore, Terry L.; Athreya, Balu H.; Lehman, Thomas.

In: Rheumatology, Vol. 48, No. 2, 2009, p. 119-122.

Research output: Contribution to journalArticle

Martini, G, Vittadello, F, Kasapçopur, Ö, Magni Manzoni, S, Corona, F, Duarte-Salazar, C, Nemcova, D, Len, CA, Garay, SM, Ullman, S, Zulian, F, Cuttica, R, Russo, R, Espada, G, Apaz, MT, Hilario, MO, Lotito, AP, Machado, C, Sztajnbok, F, De Oliveira, SKF, Liphaus, BDI, Almeida da Silva, CA, Saurenmann, T, Nielsen, S, Cate, RT, Van Suijlekom-Smit, L, Girschick, H, Foeldvari, I, Horneff, G, Wouters, C, Galea, P, Woo, P, Merino, R, Roldan Molina, R, Gàmir, ML, Ros, J, Fischbach, M, Ravelli, A, Buoncompagni, A, Cortis, E, Falcini, F, Alpigiani, MG, Ferri, C, Scegolev, A, Němcová, D, Orbàn, I, Zielińska, HM, Musiej-Nowakowska, E, Avcin, T, Srdjan, P, Stojanovic, R, Susic, G, Masha, M, Uziel, Y, Lyskina, GA, Al-Mayouf, S, Eberhard, A, Higgins, G, Punaro, L, Nelson, A, Sundel, R, Moore, TL, Athreya, BH & Lehman, T 2009, 'Factors affecting survival in juvenile systemic sclerosis', Rheumatology, vol. 48, no. 2, pp. 119-122. https://doi.org/10.1093/rheumatology/ken388
Martini G, Vittadello F, Kasapçopur Ö, Magni Manzoni S, Corona F, Duarte-Salazar C et al. Factors affecting survival in juvenile systemic sclerosis. Rheumatology. 2009;48(2):119-122. https://doi.org/10.1093/rheumatology/ken388
Martini, G. ; Vittadello, F. ; Kasapçopur, Ö ; Magni Manzoni, S. ; Corona, F. ; Duarte-Salazar, C. ; Nemcova, D. ; Len, C. A. ; Garay, S. M. ; Ullman, S. ; Zulian, F. ; Cuttica, Ruben ; Russo, Ricardo ; Espada, Graciela ; Apaz, María Teresa ; Hilario, Maria Odete ; Lotito, Ana Paola ; Machado, Claudia ; Sztajnbok, Flavio ; De Oliveira, Sheila Knupp F ; Liphaus, Bernadete de I ; Almeida da Silva, Clovis A. ; Saurenmann, Traudel ; Nielsen, Susan ; Cate, Rebecca Ten ; Van Suijlekom-Smit, Lisette ; Girschick, Hermann ; Foeldvari, Ivan ; Horneff, Gerd ; Wouters, Carine ; Galea, Paul ; Woo, Patricia ; Merino, Rosa ; Roldan Molina, Rosa ; Gàmir, Maria Luz ; Ros, Joan ; Fischbach, Michel ; Ravelli, Angelo ; Buoncompagni, Antonella ; Cortis, Elisabetta ; Falcini, Fernanda ; Alpigiani, Maria Giannina ; Ferri, Clodoveo ; Scegolev, Andrey ; Němcová, Dana ; Orbàn, Ilonka ; Zielińska, Henryka Mazur ; Musiej-Nowakowska, Elzbieta ; Avcin, Tadej ; Srdjan, Pasic ; Stojanovic, Roksanda ; Susic, Gordana ; Masha, Mukamel ; Uziel, Yoseph ; Lyskina, Galina A. ; Al-Mayouf, Sulaiman ; Eberhard, Anne ; Higgins, Gloria ; Punaro, Lynn ; Nelson, Audrey ; Sundel, Robert ; Moore, Terry L. ; Athreya, Balu H. ; Lehman, Thomas. / Factors affecting survival in juvenile systemic sclerosis. In: Rheumatology. 2009 ; Vol. 48, No. 2. pp. 119-122.
@article{97081b0fc78c4f108215bba4ae9cca84,
title = "Factors affecting survival in juvenile systemic sclerosis",
abstract = "Objectives. To determine whether demographic, clinical and immunological features may predict the outcome in juvenile SSc (JSSc). Methods. Clinical and laboratory characteristics of patients with JSSc collected from paediatric rheumatology centres worldwide were analysed. First, univariate tests identified those features significantly related with fatal outcome, and then multivariate logistic regression analysis was applied to determine the predictors of mortality. Results. One hundred and thirty-four patients from 40 centres were eligible for the analysis. Sixteen patients died and a rapidly fatal course was observed in most of them: 4/16 died within 1 yr after diagnosis and 10/16 within 5 yrs. At the moment of diagnosis, patients with poor outcome showed a significantly higher frequency of internal organ involvement, particularly cardiac, respiratory and gastrointestinal systems. No significant difference emerged for entity of skin, vascular and musculo-skeletal involvement, nor for auto-antibodies profile and laboratory tests. Multivariate analysis showed the following factors to be significant predictors of mortality: fibrosis on chest X-rays [odds ratio (OR) 11.2], raised creatinine levels (OR 22.7) and pericarditis (OR 41.3), while a short disease duration at diagnosis conferred protection (OR 0.3). Conclusions. All patients with JSSc and fatal outcome were affected by the diffuse form of the disease, and most of them showed a very rapid progression and early signs of internal organ involvement. This suggests that, in children, SSc may have two possible courses: a rapid development of internal organ failure leading to severe disability and eventually to death, or a slow course of the disease with lower mortality.",
keywords = "Child, Mortality, Outcome, Scleroderma, Systemic sclerosis",
author = "G. Martini and F. Vittadello and {\"O} Kasap{\cc}opur and {Magni Manzoni}, S. and F. Corona and C. Duarte-Salazar and D. Nemcova and Len, {C. A.} and Garay, {S. M.} and S. Ullman and F. Zulian and Ruben Cuttica and Ricardo Russo and Graciela Espada and Apaz, {Mar{\'i}a Teresa} and Hilario, {Maria Odete} and Lotito, {Ana Paola} and Claudia Machado and Flavio Sztajnbok and {De Oliveira}, {Sheila Knupp F} and Liphaus, {Bernadete de I} and {Almeida da Silva}, {Clovis A.} and Traudel Saurenmann and Susan Nielsen and Cate, {Rebecca Ten} and {Van Suijlekom-Smit}, Lisette and Hermann Girschick and Ivan Foeldvari and Gerd Horneff and Carine Wouters and Paul Galea and Patricia Woo and Rosa Merino and {Roldan Molina}, Rosa and G{\`a}mir, {Maria Luz} and Joan Ros and Michel Fischbach and Angelo Ravelli and Antonella Buoncompagni and Elisabetta Cortis and Fernanda Falcini and Alpigiani, {Maria Giannina} and Clodoveo Ferri and Andrey Scegolev and Dana Němcov{\'a} and Ilonka Orb{\`a}n and Zielińska, {Henryka Mazur} and Elzbieta Musiej-Nowakowska and Tadej Avcin and Pasic Srdjan and Roksanda Stojanovic and Gordana Susic and Mukamel Masha and Yoseph Uziel and Lyskina, {Galina A.} and Sulaiman Al-Mayouf and Anne Eberhard and Gloria Higgins and Lynn Punaro and Audrey Nelson and Robert Sundel and Moore, {Terry L.} and Athreya, {Balu H.} and Thomas Lehman",
year = "2009",
doi = "10.1093/rheumatology/ken388",
language = "English (US)",
volume = "48",
pages = "119--122",
journal = "Rheumatology (United Kingdom)",
issn = "1462-0324",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Factors affecting survival in juvenile systemic sclerosis

AU - Martini, G.

AU - Vittadello, F.

AU - Kasapçopur, Ö

AU - Magni Manzoni, S.

AU - Corona, F.

AU - Duarte-Salazar, C.

AU - Nemcova, D.

AU - Len, C. A.

AU - Garay, S. M.

AU - Ullman, S.

AU - Zulian, F.

AU - Cuttica, Ruben

AU - Russo, Ricardo

AU - Espada, Graciela

AU - Apaz, María Teresa

AU - Hilario, Maria Odete

AU - Lotito, Ana Paola

AU - Machado, Claudia

AU - Sztajnbok, Flavio

AU - De Oliveira, Sheila Knupp F

AU - Liphaus, Bernadete de I

AU - Almeida da Silva, Clovis A.

AU - Saurenmann, Traudel

AU - Nielsen, Susan

AU - Cate, Rebecca Ten

AU - Van Suijlekom-Smit, Lisette

AU - Girschick, Hermann

AU - Foeldvari, Ivan

AU - Horneff, Gerd

AU - Wouters, Carine

AU - Galea, Paul

AU - Woo, Patricia

AU - Merino, Rosa

AU - Roldan Molina, Rosa

AU - Gàmir, Maria Luz

AU - Ros, Joan

AU - Fischbach, Michel

AU - Ravelli, Angelo

AU - Buoncompagni, Antonella

AU - Cortis, Elisabetta

AU - Falcini, Fernanda

AU - Alpigiani, Maria Giannina

AU - Ferri, Clodoveo

AU - Scegolev, Andrey

AU - Němcová, Dana

AU - Orbàn, Ilonka

AU - Zielińska, Henryka Mazur

AU - Musiej-Nowakowska, Elzbieta

AU - Avcin, Tadej

AU - Srdjan, Pasic

AU - Stojanovic, Roksanda

AU - Susic, Gordana

AU - Masha, Mukamel

AU - Uziel, Yoseph

AU - Lyskina, Galina A.

AU - Al-Mayouf, Sulaiman

AU - Eberhard, Anne

AU - Higgins, Gloria

AU - Punaro, Lynn

AU - Nelson, Audrey

AU - Sundel, Robert

AU - Moore, Terry L.

AU - Athreya, Balu H.

AU - Lehman, Thomas

PY - 2009

Y1 - 2009

N2 - Objectives. To determine whether demographic, clinical and immunological features may predict the outcome in juvenile SSc (JSSc). Methods. Clinical and laboratory characteristics of patients with JSSc collected from paediatric rheumatology centres worldwide were analysed. First, univariate tests identified those features significantly related with fatal outcome, and then multivariate logistic regression analysis was applied to determine the predictors of mortality. Results. One hundred and thirty-four patients from 40 centres were eligible for the analysis. Sixteen patients died and a rapidly fatal course was observed in most of them: 4/16 died within 1 yr after diagnosis and 10/16 within 5 yrs. At the moment of diagnosis, patients with poor outcome showed a significantly higher frequency of internal organ involvement, particularly cardiac, respiratory and gastrointestinal systems. No significant difference emerged for entity of skin, vascular and musculo-skeletal involvement, nor for auto-antibodies profile and laboratory tests. Multivariate analysis showed the following factors to be significant predictors of mortality: fibrosis on chest X-rays [odds ratio (OR) 11.2], raised creatinine levels (OR 22.7) and pericarditis (OR 41.3), while a short disease duration at diagnosis conferred protection (OR 0.3). Conclusions. All patients with JSSc and fatal outcome were affected by the diffuse form of the disease, and most of them showed a very rapid progression and early signs of internal organ involvement. This suggests that, in children, SSc may have two possible courses: a rapid development of internal organ failure leading to severe disability and eventually to death, or a slow course of the disease with lower mortality.

AB - Objectives. To determine whether demographic, clinical and immunological features may predict the outcome in juvenile SSc (JSSc). Methods. Clinical and laboratory characteristics of patients with JSSc collected from paediatric rheumatology centres worldwide were analysed. First, univariate tests identified those features significantly related with fatal outcome, and then multivariate logistic regression analysis was applied to determine the predictors of mortality. Results. One hundred and thirty-four patients from 40 centres were eligible for the analysis. Sixteen patients died and a rapidly fatal course was observed in most of them: 4/16 died within 1 yr after diagnosis and 10/16 within 5 yrs. At the moment of diagnosis, patients with poor outcome showed a significantly higher frequency of internal organ involvement, particularly cardiac, respiratory and gastrointestinal systems. No significant difference emerged for entity of skin, vascular and musculo-skeletal involvement, nor for auto-antibodies profile and laboratory tests. Multivariate analysis showed the following factors to be significant predictors of mortality: fibrosis on chest X-rays [odds ratio (OR) 11.2], raised creatinine levels (OR 22.7) and pericarditis (OR 41.3), while a short disease duration at diagnosis conferred protection (OR 0.3). Conclusions. All patients with JSSc and fatal outcome were affected by the diffuse form of the disease, and most of them showed a very rapid progression and early signs of internal organ involvement. This suggests that, in children, SSc may have two possible courses: a rapid development of internal organ failure leading to severe disability and eventually to death, or a slow course of the disease with lower mortality.

KW - Child

KW - Mortality

KW - Outcome

KW - Scleroderma

KW - Systemic sclerosis

UR - http://www.scopus.com/inward/record.url?scp=58749089682&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58749089682&partnerID=8YFLogxK

U2 - 10.1093/rheumatology/ken388

DO - 10.1093/rheumatology/ken388

M3 - Article

C2 - 18854345

AN - SCOPUS:58749089682

VL - 48

SP - 119

EP - 122

JO - Rheumatology (United Kingdom)

JF - Rheumatology (United Kingdom)

SN - 1462-0324

IS - 2

ER -